Today news
The same in other media
Newly approved COVID-19 pills come with a catch. Here’s what you should know
Reading now: 822
Newly infected COVID-19 patients have two new treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear.
The challenge is getting tested, getting a prescription and starting the pills in a short window. Read more: Canada secures orders of Merck, Pfizer COVID-19 antiviral pills U.S.
regulators authorized Pfizer’s pill, Paxlovid, and Merck’s molnupiravir this week. In high-risk patients, both were shown to reduce the chances of hospitalization or death from COVID-19, although Pfizer’s was much more effective.
Here’s a closer look: The antiviral pills aren’t for everyone who gets a positive test. The pills are intended for those with mild or
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|